BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.pharmajournalist.com X-WR-CALDESC:Events for Pharma Journalist REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Asia/Kolkata BEGIN:STANDARD TZOFFSETFROM:+0530 TZOFFSETTO:+0530 TZNAME:IST DTSTART:20180101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20190205 DTEND;VALUE=DATE:20190207 DTSTAMP:20260514T224137 CREATED:20181003T111236Z LAST-MODIFIED:20181003T112508Z UID:17870-1549324800-1549497599@www.pharmajournalist.com SUMMARY:13th Annual Parallel Trade Conference 2019 DESCRIPTION:SMi presents its 13th annual Parallel Trade conference\, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe\, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. \n \nThe 2019 event is particularly valuable since Brexit and the news of the UK officially leaving the EU on the 29th of March 2019. As such\, the UK will no longer be part of the EU free market; hence\, having a significant impact on parallel trade. \nFurthermore\, the FMD (Falsified Medicines Directive) will be coming into effect in February 2019. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market. \n\nTo learn more about this event\, and to register online\, visit www.parallel-trade.com/PharmaJ URL:https://www.pharmajournalist.com/event/13th-annual-parallel-trade-conference-2019/ LOCATION:Holiday Inn\, Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190206 DTEND;VALUE=DATE:20190208 DTSTAMP:20260514T224137 CREATED:20190124T072816Z LAST-MODIFIED:20190124T072816Z UID:19187-1549411200-1549583999@www.pharmajournalist.com SUMMARY:Outsourcing in Clinical Trials: Medical Devices Europe 2019 DESCRIPTION:The 6th annual Outsourcing in Clinical Trials Media Devices Europe Conference returns yet again in 2019! \nThe event will bring together trial sponsors rom across Europe for 2 days\, providing engaging presentations from the biggest names in the sector. \nThe 2019 programme will feature the latest industry trends and outsourcing challenges for the European medical device and diagnostics community. We’ll be exploring the latest regulatory challenges for medical device manufacturers and the opportunities for greater efficiency in trials. \nWe look forward to seeing you there! URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-medical-devices-europe-2019/ LOCATION:Hilton Munich Airport Terminalstraße Mitte 20 85356 ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190212 DTEND;VALUE=DATE:20190214 DTSTAMP:20260514T224137 CREATED:20190124T073216Z LAST-MODIFIED:20190124T073216Z UID:19191-1549929600-1550102399@www.pharmajournalist.com SUMMARY:Outsourcing in Clinical Trials West Coast 2019 DESCRIPTION:After record-breaking attendance in 2018\, Arena International’s flagship Outsourcing in Clinical Trials West Coast conference returns to the Bay Area for its 11th year in February 2019. \nWith 6 tracks spanning across 2 days\, the 2019 event is guaranteed to provide you with practical takeaways to help you accelerate your clinical trial timelines as well as insider knowledge on new innovations and technological advancements in the industry. \nFocused on enabling collaboration between the clinical trials community in the Bay Area\, the 2019 agenda is jam-packed with interactive sessions such as fireside chats\, panel discussions\, think-tanks and more. Whether you want to dive into a presentation on digital biomarkers or a panel discussion on measuring the health of your vendor partnerships\, there is something for everyone at the upcoming meeting. \nDon’t miss out on; join us in Burlingame on 12-13 February by registering your place today! URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-west-coast-2019/ LOCATION:Hyatt Regency San Francisco Airport Hotel 1333 Bayshore Highway Burlingame 94010 ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190219 DTEND;VALUE=DATE:20190221 DTSTAMP:20260514T224137 CREATED:20180926T073514Z LAST-MODIFIED:20180926T073514Z UID:17758-1550534400-1550707199@www.pharmajournalist.com SUMMARY:Pharma Security Asia 2019 DESCRIPTION:The importance of the pharmaceutical industry in the modern-day Asian society cannot be overstressed especially as there are new diseases springing up from different areas\, strengthening the importance of adequate drug research and development activities. However\, with the growth of the industry in Asia comes the increase in fake drugs. In recent times\, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO)\, about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate\, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales.\nWe require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters.\nThus\, To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security Asia 2019 – An Anti-Counterfeiting\, Drug Serialization and Supply-Chain Security Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. \nSocial Media: \n@corvusglobal\nhttps://www.facebook.com/corvusglobalevents/\nhttps://twitter.com/corvusglobal?lang=en URL:https://www.pharmajournalist.com/event/pharma-security-asia-2019/ LOCATION:Singapore\, Singapore ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190219 DTEND;VALUE=DATE:20190222 DTSTAMP:20260514T224137 CREATED:20181123T082750Z LAST-MODIFIED:20181123T082750Z UID:18485-1550534400-1550793599@www.pharmajournalist.com SUMMARY:7th World CNS Summit DESCRIPTION:The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research. \n \nWorld CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees\, helping to overcome the translational challenges in developing efficacious therapeutics. \nDeveloped in combination with experts from Biogen\, Eisai\, Merck\, AbbVie and other leading organizations\, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting. \nFollowing numerous neurodegenerative disease clinical failures\, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success. \nNow in its 7th successful year\, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration\, bringing together over 150+ leading minds in the neurodegenerative space\, from academia\, pharma\, biotech and leading consortia\, to provide a unique opportunity to bridge the gap of translational drug development. \nTo learn more and to register online\, visit http://bit.ly/2AfTc9J URL:https://www.pharmajournalist.com/event/7th-world-cns-summit/ LOCATION:Seaport Hotel & World Trade Center\, One Seaport Lane\, Boston\, MA\, 02210\, United States ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190220 DTEND;VALUE=DATE:20190222 DTSTAMP:20260514T224137 CREATED:20181025T121157Z LAST-MODIFIED:20181025T121157Z UID:18118-1550620800-1550793599@www.pharmajournalist.com SUMMARY:3rd Annual 3D Cell Culture DESCRIPTION:SMi’s 3rd Annual 3D Cell Culture\nDelivering updates on the development and application of human organs and tissues in vitro\n \nProudly sponsored by InoCure & TEDD Competence Centre \nCHAIRED BY: \nNicola Valeri\, Gastrointestinal Cancer Biology and Genomics Team Leader\, The Institute of Cancer Research\nStefan Przyborski\, Professor of Cell Technology\, University of Durham \nCell Culture in an important tool for research and development within the life science industry. Over the past few years\, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions\, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring\, cell viability\, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans. \n \nResearchers globally are realizing the potential of 3D cell culture for various applications\, including testing and discovering new drugs to treat cancer\, organ-on-chip models to study the human physiology in an organ specific context\, and 3D cell printing to produce organ models. Therefore\, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022\, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting\, funding from governments and private entities and technological advancements in the field. \nAt the 3D Cell Culture Conference in February\, we will look at the latest developments in the 3D Cell Culture field. Participants will have the opportunity to network with industry experts\, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development\, discuss the potential for novel in-vitro cell culture models to replace animal models\, and discover novel 3D cell culture systems\, organ-on-chip\, 3D imaging of organoids and other technologies in development. \nEvent Hashtag: #SMi3DCellCulture \nFEATURED SPEAKERS INCLUDE: \nGUEST SPEAKER: \n\nBill Mattes\, Director\, Division of Systems Biology\, FDA \n\nSPEAKERS INCLUDE: \n\nAsli Akidil\, Cell and Molecular Scientist\, AstraZeneca\nGary Allenby\, Business Development Director and Chief Scientific Officer\, Aurelia Biosciences\nJason Ekert\, Head of Complex In Vitro Models\, GSK\nPhilip Hewitt\, UK and Eurotox Registered Toxicologist\, Head of Early Investigative Technology\, Merck\nStefan Kustermann\, Lab Head\, Investigative Safety\, Roche\nVeronique Barban\, Expert Virology\, Research and Nonclinical Safety Department\, Sanofi Pasteur\n\nKEY TOPICS FOR 2018 INCLUDE: \n\nOrgan-on-chip technologies and their applications in the pharmaceutical industry\nPanel discussion on whether 3D Cell Culture will replace animal models\nDetermining the predictive validity of 3D models and achieving standardization for preclinical testing\nGlobal developments in 3D Cell Culture and how this exponential growth will impact researchers\nSeveral novel techniques for imaging of 3D Cell Cultures\nDevelopment of 3D eye models for early assessment of retinal toxicity\nMusculoskeletal regeneration harnessing preclinical models for tissue repair\n\nView the full agenda: http://www.3d-cellculture.com/pjwl \nWHO SHOULD ATTEND \nBiotech / Pharma Companies – Team Leader\, Junior Principle investigator\, Cell and Molecular Scientist\, Chief Scientific Officer\, Deputy Director\, Manager\, Founder\, CEO\, Head\, Director\, Programme Manager\, Lab Head\, Toxicologist \nAcademia Professor – Cell Technology\, Stem Cell Sciences\, Biochemistry\, Protein Technology and Tissue Engineering \nSolution Providers – Manager\, Head of\, CEO\, Director\, Founder\, Account Manager\, President\, CSO\, Executive\, Managing Director\, Vice President\, COO \nOrganisations / Regulatory – Director\, Senior Science Advisor\, Scientific Officer  \nEARLY BIRD-RATES \n\nBOOK BY 31ST OCTOBER AND SAVE £400\nBOOK BY 30TH NOVEMBER AND SAVE £200\nBOOK BY 14TH DECEMBER AND SAVE £100 URL:https://www.pharmajournalist.com/event/3rd-annual-3d-cell-culture/ LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom ORGANIZER;CN="SMi Group Ltd.":MAILTO:ssapal@smi-online.co.uk END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190220 DTEND;VALUE=DATE:20190222 DTSTAMP:20260514T224137 CREATED:20181119T145121Z LAST-MODIFIED:20181119T145121Z UID:18459-1550620800-1550793599@www.pharmajournalist.com SUMMARY:Pharma Packaging and Labeling East Coast 2019 DESCRIPTION:Now in its 11th year\, Pharma Packaging and Labeling is back to deliver key\, actionable insights into very latest regulatory requirements\, technological innovations\, strategic developments\, and how to implement them into your packaging and labeling chain with both maximum efficiency and minimal cost. \n \nWith evolving regulations and tougher anti-counterfeiting rules\, ensuring patient safety and the right systems are in place is more crucial than ever. Meeting the deadlines and adhering to regulations will not only ensure compliance but will also deliver huge benefits to your business and the industry \nWith popular demand\, the US Drug Enforcement Agency will be back to answer questions on current anti-counterfeit regulations and how this will impact your business. The 2019 speaker line up brings together regulatory bodies and pharma companies including the DSCSA\, US Customs & Borders\, Pfizer\, Merck\, Trevena\, Biogen\, Alkermes and an insight into CMOs including PharmoRx Therapeutics\, among many others. \nPharma Packaging and Labeling will bring you everything you need to ensure a successful and compliant implementation for your packaging and labeling. With a more interactive and hands on agenda including panel discussions; roundtables; speed networking; think tanks; mini workshops and more\, this event will create an environment where commercial packaging and labeling teams from across all sizes of manufacturer can work together to manage creative\, technical\, and regulatory demands while ensuring patients are safeguarded at all stages. \nFor more details\, please visit http://www.arena-international.com/pharmapackagingeast/ URL:https://www.pharmajournalist.com/event/pharma-packaging-and-labeling-east-coast-2019/ LOCATION:Philadelphia\, Pennsylvania ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190225 DTEND;VALUE=DATE:20190227 DTSTAMP:20260514T224137 CREATED:20181206T111248Z LAST-MODIFIED:20181206T111248Z UID:18683-1551052800-1551225599@www.pharmajournalist.com SUMMARY:3rd European Clinical Quality Oversight Forum DESCRIPTION:The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting\, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing\, optimising and managing the quality of clinical vendors and sites. \n \nTo learn more about this event\, visit https://goo.gl/uPWwum URL:https://www.pharmajournalist.com/event/3rd-european-clinical-quality-oversight-forum/ LOCATION:Hilton London Canary Wharf\, South Quay\, Marsh Wall\, London\, E14 9SH\, United Kingdom ORGANIZER;CN="ExL Events":MAILTO:contact@exlevents.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190225 DTEND;VALUE=DATE:20190228 DTSTAMP:20260514T224137 CREATED:20190103T104014Z LAST-MODIFIED:20190103T104149Z UID:18924-1551052800-1551311999@www.pharmajournalist.com SUMMARY:CAR-TCR Summit Europe DESCRIPTION:The industry-focused CAR-TCR Summit Europe is dedicated to developing\, translating and delivering next generation CAR and TCR therapies for patients in Europe. \n \nJoin over 250 of Europe’s leading drug developers to learn about never-before-seen clinical updates and novel technology to improve solid tumour targeting\, advance allogeneic therapy development and automate manufacturing processes in order to create a targeted\, efficacious and commercially viable cancer therapy. \nFor more information\, visit www.cartcr-europe.com URL:https://www.pharmajournalist.com/event/car-tcr-summit-europe/ LOCATION:Novotel London West\, 1 Shortlands\, Hammersmith\, London\, W6 8DR\, United Kingdom ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190225 DTEND;VALUE=DATE:20190227 DTSTAMP:20260514T224137 CREATED:20190108T100940Z LAST-MODIFIED:20190108T100940Z UID:18951-1551052800-1551225599@www.pharmajournalist.com SUMMARY:Global NASH Congress DESCRIPTION:Attracting experts working in all areas of nonalcoholic steatohepatitis\, the Global NASH Congress will examine the latest research and development in pathogenesis\, diagnosis\, and treatment of the disease. An increasing number of people are being diagnosed with the nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year\, and the primary method of treatment is weight loss. With no approved medicines on the market\, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood\, and definitive diagnostic methods are invasive\, so development has been slow. There are\, however\, promising developments in research that will hopefully bolster drug development and other methods of treatment. Examples of such developments include improved in vivo liver models\, non-invasive diagnostic biomarkers and a better understanding of the disease’s mechanisms. This year’s congress will focus on these exciting advancements\, as well as on the challenges of preclinical and clinical research in NASH. There will also be a session on business development/regulation and a showcase of the most promising therapeutics in development. URL:https://www.pharmajournalist.com/event/global-nash-congress/ LOCATION:London\, United Kingdom\, London Heathrow Marriott Hotel\, London\, United Kingdom ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20190226 DTEND;VALUE=DATE:20190301 DTSTAMP:20260514T224137 CREATED:20190213T093921Z LAST-MODIFIED:20190214T153157Z UID:19523-1551139200-1551398399@www.pharmajournalist.com SUMMARY:AsiaTIDES: Oligonucleotide & Peptide Therapeutics DESCRIPTION:AsiaTIDES is the only event in Asia that brings together the science\, technologies and partners you need to accelerate your oligonucleotide and peptide molecules to market. Join 300+ scientists and executives at this upcoming meeting featuring keynote speakers from Novo Nordisk A/S\, Ionis Pharmaceuticals\, Alnylam Pharmaceuticals\, and WAVE Life Sciences. \n \nRegister now at www.AsiaTIDESEvent.com with code “PHARMJ10” and SAVE 10%. URL:https://www.pharmajournalist.com/event/asiatides-oligonucleotide-peptide-therapeutics/ LOCATION:Hilton Tokyo Bay Hotel | Tokyo\, Japan ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com END:VEVENT END:VCALENDAR